Jane Street’s Virax Biolabs VRAX Stock Holding History

Jane Street’s Portfolio VRAX Stock Details VRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$77.6K	Buy	+26,385	New	+$112K	﹤0.01%	10738
2024 Q4	–	Sell	-465	Closed	-$22.6K	–	10703
2024 Q3	$22.6K	Buy	+465	New	+$26.7K	﹤0.01%	9284

Other funds holding VRAX

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street's VRAX Position: Q2 2026 in Review

Jane Street opened a new position in Virax Biolabs (VRAX) in Q2 2026: 26,385 shares worth $77.6K. The stake represents ﹤0.01% of the portfolio and ranks #10738 among its holdings. This is a return to the name: Jane Street previously reported a position in VRAX as recently as Q3 2024.

Jane Street first reported a position in VRAX in Q3 2024 and has held it in 2 quarters since. 2 funds tracked by Wall St. Rank hold VRAX as of Q2 2026.

Jane Street held 26,385 shares of Virax Biolabs worth $77.6K as of Q2 2026.
Virax Biolabs was a new Jane Street position in Q2 2026.
Virax Biolabs made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10738 holding.
Jane Street first reported a position in Virax Biolabs in Q3 2024 and has held it in 2 quarters since.
2 funds tracked by Wall St. Rank held Virax Biolabs as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.